92656 Aliso Viejo, CA, us
Microsemi Announces New Package for Radiation Tolerant "Space Flight" FPGAs
RT ProASIC®3 Offered in Robust Ceramic Package
Microsemi's RT ProASIC3 FPGAs are the first devices of their type to provide space-flight hardware designers a radiation-tolerant, reprogrammable, non-volatile logic integration solution. The devices are intended for low-power space applications requiring up to 350 MHz operation and up to 3 million system gates. The devices operate at a core voltage between 1.2 V for low-power applications and 1.5 V for performance-driven designs.
The RT ProASIC3 FPGAs are based on secure flash technology that provides immunity against damaging radiation-induced configuration upsets, while eliminating the need for additional code storage. The easily reprogrammable FPGAs also enable quick prototyping and design validation capabilities, which streamline product-development efforts.
Microsemi has been providing solutions for demanding space applications for more than 40 years and currently has more than 150 fully qualified space products in its portfolio. The company's standard and customized space solutions include converters, customizable system-on-chip (cSoC) solutions, MOSFETS, rectifiers, switching diodes, transistors, DC-DC converters and zener diodes.
RT ProASIC3 FPGAs in the CQ256 package will be available for prototyping in April 2012 with flight units available by June 2012. For additional information about the RT ProASIC3 FPGA product family, visit www.microsemi.com/soc/ or contact a local Microsemi sales representative.
Microsemi and the Microsemi logo are registered trademarks or service marks of Microsemi Corporation and/or its affiliates. Third-party trademarks and service marks mentioned herein are the property of their respective owners.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Any statements set forth in this news release that are not entirely historical and factual in nature, including without limitation statements related to its new RT ProASIC3 CQFP package, and its potential effects on future business, are forward-looking statements. These forward-looking statements are based on our current expectations and are inherently subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. The potential risks and uncertainties include, but are not limited to, such factors as rapidly changing technology and product obsolescence, potential cost increases, variations in customer order preferences, weakness or competitive pricing environment of the marketplace, uncertain demand for and acceptance of the company's products, adverse circumstances in any of our end markets, results of in-process or planned development or marketing and promotional campaigns, difficulties foreseeing future demand, potential non-realization of expected orders or non-realization of backlog, product returns, product liability, and other potential unexpected business and economic conditions or adverse changes in current or expected industry conditions, difficulties and costs of protecting patents and other proprietary rights, inventory obsolescence and difficulties regarding customer qualification of products. In addition to these factors and any other factors mentioned elsewhere in this news release, the reader should refer as well to the factors, uncertainties or risks identified in the company's most recent Form 10-K and all subsequent Form 10-Q reports filed by Microsemi with the SEC. Additional risk factors may be identified from time to time in Microsemi's future filings. The forward-looking statements included in this release speak only as of the date hereof, and Microsemi does not undertake any obligation to update these forward-looking statements to reflect subsequent events or circumstances.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.